Trade Names: | |
Synonyms: | |
Status: | Approved (2011) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
ATC: | V03AB08 |
UNII: | M0KG633D4F |
InChI Key | LPXPTNMVRIOKMN-UHFFFAOYSA-M |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | NNaO2 |
Molecular Weight | 69.0 |
AlogP | 0.14 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 0.0 |
Polar Surface Area | 49.66 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 3.0 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Poisoning | 4 | D011041 | FDA |
Acute Kidney Injury | 3 | D058186 | ClinicalTrials |
Hypertension, Pulmonary | 2 | D006976 | ClinicalTrials |
Diabetes Mellitus | 2 | D003920 | ClinicalTrials |
Peripheral Arterial Disease | 2 | D058729 | ClinicalTrials |
Anemia, Sickle Cell | 2 | D000755 | ClinicalTrials |
Aging | 2 | D000375 | ClinicalTrials |
Asthma | 2 | D001249 | ClinicalTrials |
Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
Myocardial Infarction | 2 | D009203 | ClinicalTrials |
Subarachnoid Hemorrhage | 2 | D013345 | ClinicalTrials |
Heart Arrest | 2 | D006323 | ClinicalTrials |
Hypertension, Pulmonary | 2 | D006976 | ClinicalTrials |
Heart Failure | 2 | D006333 | ClinicalTrials |
ST Elevation Myocardial Infarction | 2 | D000072657 | ClinicalTrials |
Cystic Fibrosis | 1 | D003550 | ClinicalTrials |
Malaria, Falciparum | 1 | D016778 | ClinicalTrials |
Hypertension | 1 | D006973 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 78870 |
ChEMBL | CHEMBL93268 |
EPA CompTox | DTXSID0020941 |
FDA SRS | M0KG633D4F |
PharmGKB | PA166115361 |
PubChem | 23668193 |
SureChEMBL | SCHEMBL341 |